The European Union Drugs Agency (EUDA) is teaming up with the Brazilian Secretaria Nacional de Políticas sobre Drogas e Gestão de Ativos (SENAD) this week to host a series of evidence-based prevention events in Brasília. The events aim to strengthen prevention efforts in Latin America by fostering the use of scientifically proven strategies.
The first event is a European Prevention Curriculum (EUPC) basic training course, being delivered in Portuguese to Brazilian prevention experts (27–28 August). The Portuguese version of the course, adapted to the Brazilian context, was a joint initiative…
Čtěte více
What are psychedelic substances? Why are they currently being researched in the medical field? Are psychedelics already available for treatment in Europe? These are some of the issues addressed in a new set of EUDA Frequently Asked Questions (FAQs): therapeutic use of psychedelic substances released today.
The FAQs are published in response to the growing interest in the therapeutic use of psychedelic substances and the need for reliable information on the topic. The digital resource is based on the findings from an EUDA project to develop a better understanding of key developments in this…
Čtěte více
Eliminating viral hepatitis as a public health threat by 2030 is a target set under the UN Sustainable Development Goal on Health (SDG 3.3) (1). Ahead of World Hepatitis Day on 28 July, the EUDA has released today an update of its interactive elimination barometer designed to support countries in monitoring their progress towards the elimination of viral hepatitis among people who inject drugs.
Hepatitis C virus (HCV) infection is the infectious disease associated with the highest burden of disease among people who inject drugs (PWID), the virus being easily transmitted through the…
Čtěte více
